重型COVID-19患者血液净化治疗方案专家建议
该专家建议基于严重急性呼吸综合征和中东呼吸综合征的血液净化经验及临床一线实践制定,针对重型COVID-19患者。方案分为四步:第一步评估是否需要血液净化;第二步开具血液净化治疗处方;第三步监测并调整血液净化参数;第四步评估停止血液净化的时机。流行病学数据显示至少20%的COVID-19患者为重型,急性肾损伤是主要并发症,细胞因子风暴介导的免疫损伤和合并急性肾损伤是预后不良的关键因素。通过标准化实施方案,血液净化有望在有效降低重型COVID-19患者死亡率方面发挥关键作用。
要点
- 至少20%的COVID-19患者为重型,急性肾损伤是主要并发症。
- 细胞因子风暴介导的免疫损伤和合并急性肾损伤是重型COVID-19患者预后不良的关键因素。
- 血液净化方案分为四步:评估是否需要、开具处方、监测调整参数、评估停止时机。
- 方案基于严重急性呼吸综合征和中东呼吸综合征的血液净化经验及临床一线实践制定。
- 标准化实施本方案有望有效降低重型COVID-19患者死亡率。
适用人群与场景
- 重型COVID-19患者。
处置流程与药物剂量
- 第一步:评估重型COVID-19患者是否需要血液净化。
- 第二步:为COVID-19患者开具血液净化治疗处方。
- 第三步:监测并调整血液净化参数。
- 第四步:评估停止血液净化的时机。
研究设计与关键结果
- 流行病学数据显示至少20%的COVID-19患者为重型。
- 除呼吸系统损害外,急性肾损伤是主要并发症。
- 细胞因子风暴介导的免疫损伤和合并急性肾损伤是预后不良的关键因素。
证据类型、等级与局限
- 证据类型:专家建议。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,通过标准化实施本血液净化方案,有望有效降低重型COVID-19患者死亡率。
指南或共识出处
- Expert recommendations on blood purification treatment protocol for patients with severe COVID-19(Chronic Dis Transl Med)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Coronavirus disease (COVID-19) was first diagnosed in Wuhan in December 2019. The World Health Organization defined the subsequent outbreak of COVID-19 worldwide as a public health emergency of international concern. Epidemiological data indicate that at least 20% of COVID-19 patients have severe disease. In addition to impairment of the respiratory system, acute kidney injury (AKI) is a major complication. Immune damage mediated by cytokine storms and concomitant AKI is a key factor for poor prognosis. Based on previous experience of blood purification for patients with severe acute respiratory syndrome and Middle East respiratory syndrome combined with clinical front-line practice, we developed a blood purification protocol for patients with severe COVID-19. This protocol is divided into four major steps. The first step is to assess whether patients with severe COVID-19 require blood purification. The second step is to prescribe a blood purification treatment for patients with COVID-19. The third step is to monitor and adjust parameters of blood purification. The fourth step is to evaluate the timing of discontinuation of blood purification. It is expected that blood purification will play a key role in effectively reducing the mortality of patients with severe COVID-19 through the standardized implementation of the present protocol.
参考来源
- Yang XH, Sun RH, Zhao MY, et al. Expert recommendations on blood purification treatment protocol for patients with severe COVID-19. Chronic Dis Transl Med. 2020. PMID: 32346492. doi:10.1016/j.cdtm.2020.04.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。